1. Home
  2. Sistema de Salut de Catalunya
  3. Vall d'Hebron Hospital Universitari – HVH
  4. Articles científics - HVH
  5. View Item

Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma

To access the full text documents, please follow this link: https://hdl.handle.net/11351/12439

Author

Di Staso, Rossana

Casadei, Beatrice

Locke, Frederick

Voorhees, Timothy

Kittai, Adam

Jain, Michael

Barba, Pere

IACOBONI, GLORIA

Other authors

Institut Català de la Salut

[Di Staso R] Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. [Casadei B] IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy. [Locke FL, Jain M] Moffitt Cancer Center, Tampa, FL, USA. [Voorhees TJ, Kittai AS] Division of Hematology, The Ohio State University, Columbus, OH, USA. [Iacoboni G, Barba P] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain

Vall d'Hebron Barcelona Hospital Campus

Publication date

2025-01-20T10:08:02Z

2025-01-20T10:08:02Z

2024-11-07



Share

Abstract

CAR-T cells; Diffuse large B cell lymphoma

Células CAR-T; Linfoma difuso de células B grandes

Cèl·lules CAR-T; Limfoma difús de cèl·lules B grans

Funding was provided by Alma Mater Studiorum- University of Bologna (ID grant: ALMA IDEA 2022 CUP:J33C22001420001). We thank Massimo Agostini for data entry and AIL Bologna OdV (prot 2CSAIL21 Argnani).

Document Type

Article

Published version

Language

English

Subjects and keywords

Cèl·lules T; Cèl·lules B - Tumors - Immunoteràpia; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy::Immunization::Immunization, Passive::Adoptive Transfer::Immunotherapy, Adoptive; DISEASES::Neoplasms::Neoplasms by Histologic Type::Lymphoma::Lymphoma, Non-Hodgkin::Lymphoma, B-Cell::Lymphoma, Large B-Cell, Diffuse; Other subheadings::Other subheadings::Other subheadings::/drug therapy; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia::inmunización::inmunización pasiva::transferencia adoptiva::inmunoterapia adoptiva; ENFERMEDADES::neoplasias::neoplasias por tipo histológico::linfoma::linfoma no Hodgkin::linfoma de células B::linfoma de células B grandes difuso; Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia

Publisher

Springer Nature

Related items

Blood Cancer Journal;14

https://doi.org/10.1038/s41408-024-01183-8

Recommended citation

This citation was generated automatically.

Export

DIDL MARC MARC_CCUC METS OAI_DC ORE QDC RDF

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International

http://creativecommons.org/licenses/by-nc-nd/4.0/

This item appears in the following Collection(s)

Articles científics - HVH [3440]